This Article Full Text Full Text (PDF) Data Supplement Correction (v25,pe128) All Versions of this Article: 25/6/1206    most recent 01.ATV.0000164805.73558.80v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Robbesyn, F. Articles by Salvayre, R. Search for Related Content PubMed PubMed Citation Articles by Robbesyn, F. Articles by Salvayre, R. Related Collections Cell signalling/signal transduction Lipid and lipoprotein metabolism Oxidant stress Mechanism of atherosclerosis/growth factors

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1206.)
© 2005 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

High-Density Lipoproteins Prevent the Oxidized Low-Density Lipoprotein–Induced Endothelial Growth Factor Receptor Activation and Subsequent Matrix Metalloproteinase-2 Upregulation

Fanny Robbesyn; Nathalie Augé; Cécile Vindis; Anne-Valérie Cantero; Ronald Barbaras; Anne Negre-Salvayre; Robert Salvayre

From INSERM U-466 and Biochimie IFR-31 (F.R., N.A., C.V., A.-V.C., A.N.-S., R.S.), Faculty of Medicine, University Paul Sabatier, Toulouse, France; INSERM U-563 (R.B.), Centre de Physiopathologie de Toulouse-Purpan, Department Lipoproteines et Mediateurs Lipidiques, IFR-30, Toulouse, France.

Correspondence to R. Salvayre or A. Negre-Salvayre, Biochimie, INSERM U466, IFR-31, CHU Rangueil, 1, avenue Jean Poulhès, TSA-50032, 31059 Toulouse Cedex 9, France. E-mail salvayre{at}toulouse.inserm.fr or anesalv@toulouse.inserm.fr

Objectives— The atherogenic oxidized low-density lipoprotein (oxLDL) induces the formation of carbonyl-protein adducts and activates the endothelial growth factor receptor (EGFR) signaling pathway, which is now regarded as a central element for signal transduction. We aimed to investigate whether and by which mechanism the anti-atherogenic high-density lipoprotein (HDL) prevents these effects of oxLDL.

Methods and Results— In vascular cultured cells, HDL and apolipoprotein A-I inhibit oxLDL-induced EGFR activation and subsequent signaling by acting through 2 separate mechanisms. First, HDL, like the aldehyde scavenger dinitrophenyl hydrazine, prevented the formation of oxLDL-induced carbonyl–protein adducts and 4-hydroxynonenal (HNE)–EGFR adducts. Secondly, HDL enhanced the cellular antioxidant defenses by preventing (through a scavenger receptor class B-1 (SR-BI)–dependent mechanism) the increase of intracellular reactive oxygen species (ROS) and subsequent EGFR activation triggered by oxLDL or H₂O₂. A pharmacological approach suggests that this protective effect of HDL is independent of cellular glutathione level and glutathione peroxidase activity, but it requires catalase activity. Finally, we report that oxLDL upregulates both membrane type 1 (MT1)-matrix metalloproteinase-1 (MT1-MMP) and MMP-2 through an EGFR-dependent mechanism and that HDL inhibits these events.

Conclusions— HDLs block in vitro oxLDL-induced EGFR signaling and subsequent MMP-2 activation by inhibiting carbonyl adducts formation and cellular oxidative stress. These effects of HDL may participate to reduce cell activation, excessive remodeling, and alteration of the vascular wall.

Oxidized LDLs induce EGFR activation and subsequent MMP-2 activation. HDLs inhibit these events by 2 separate mechanisms, ie, by blocking carbonyl–protein adduct formation and by inhibiting the oxLDL-induced and H₂O₂-induced intracellular ROS increase, through a catalase-dependent process. This may contribute to reduce cell activation, excessive remodeling, and vascular wall alteration.

Key Words: atherosclerosis • endothelial growth factors • lipoproteins

This article has been cited by other articles:

				K.C.Y. McGrath, X.H. Li, R. Puranik, E.C. Liong, J.T.M. Tan, V.M. Dy, B.A. DiBartolo, P.J. Barter, K.A. Rye, and A.K. Heather Role of 3{beta}-Hydroxysteroid-{Delta}24 Reductase in Mediating Antiinflammatory Effects of High-Density Lipoproteins in Endothelial Cells Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 877 - 882. [Abstract] [Full Text] [PDF]

				R. Simo, M. Higuera, M. Garcia-Ramirez, F. Canals, J. Garcia-Arumi, and C. Hernandez Elevation of Apolipoprotein A-I and Apolipoprotein H Levels in the Vitreous Fluid and Overexpression in the Retina of Diabetic Patients Arch Ophthalmol, August 1, 2008; 126(8): 1076 - 1081. [Abstract] [Full Text] [PDF]

				X. W. Cheng, T. Murohara, M. Kuzuya, H. Izawa, T. Sasaki, K. Obata, K. Nagata, T. Nishizawa, M. Kobayashi, T. Yamada, et al. Superoxide-Dependent Cathepsin Activation Is Associated with Hypertensive Myocardial Remodeling and Represents a Target for Angiotensin II Type 1 Receptor Blocker Treatment Am. J. Pathol., August 1, 2008; 173(2): 358 - 369. [Abstract] [Full Text] [PDF]